<DOC>
	<DOCNO>NCT00185757</DOCNO>
	<brief_summary>The purpose study determine use activate T cell effectively treat relapsed disease follow allogeneic hematopoietic cell transplantation without cause GVHD .</brief_summary>
	<brief_title>Cytokine Induced Killer Cells Post-Transplant Immunotherapy Following Allogeneic Hematopoietic Cell Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<criteria>Evidence recurrent persistent hematologic malignancy follow HLA match allogeneic hematopoietic cell transplant eligible DLI evidence GVHD stable immunosuppressive regimen adequate renal liver function CML patient receive DLI , active infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>